At present, the statistical caliber of the domestic pharmaceutical hollow capsule market size and status quo is not consistent, there is a big difference between the data. Therefore, the market size of the pharmaceutical hollow capsule industry can be measured by the pharmaceutical industry data.
Medicinal hollow capsules are mainly used in capsule products in preparations such as chemicals, biochemical products and proprietary Chinese medicines. According to the production data of the Chemical Pharmaceuticals Division of the 2013 China Pharmaceutical Statistics Annual Report and the Chinese Medicine Biopharmaceuticals Volume, the total capsule production in the chemical products in 2013 and the capsule production in the Chinese patent medicines totaled approximately 231,18,762,000. According to the demand for medicinal hollow capsules of health care products, which accounted for 10% of the total demand of the industry, the market demand for medicinal hollow capsules in China was about 25,531,965,380. According to the average price of medicinal hollow capsules of 100 yuan / 10,000 tablets, the market capacity of medicinal hollow capsules in China in 2013 was about 2.321 billion yuan to 2.553 billion yuan.
In the future, the market capacity of China's medical hollow capsules will be further expanded. First of all, the scale of China's pharmaceutical industry will continue to grow rapidly, thus providing guarantee for the expansion of the pharmaceutical hollow capsule industry. According to the “Analysis of the Economic Operation of the Pharmaceutical Industry in 2014” issued by the Ministry of Industry and Information Technology of the People's Republic of China, in 2014, the enterprises above designated size of the pharmaceutical industry realized a revenue of RMB 245.316 billion, a year-on-year increase of 13.05%. BCG expects the average annual growth rate of the pharmaceutical market to reach 13%-15% by 2020, although it is lower than the development target of 20% annual growth expected by the Pharmaceutical Industry 12th Five-Year Development Plan, but this development rate Still very impressive.
By 2015, the national pharmaceutical output value will increase from 1,242.7 billion yuan in 2010 to 3,022.2 billion yuan. Secondly, the state has established a graded medical system and a basic drug system to continuously promote the expansion of the primary health care market. According to China's Samsung Economic Research Institute's special report "Competition Status of China's Pharmaceutical Industry", the scale of pharmaceutical retail third terminals increased from 54 billion yuan in 2007 to 130 billion yuan in 2010, with an average annual compound growth rate of 34.02%; With the continuous deepening of the globalization of international medicine, the pharmaceutical manufacturing process has gradually shifted to emerging market countries. Due to the rapid growth in demand for health care and the obvious advantages of R&D and production costs, China has become one of the key areas for the global pharmaceutical industry. Therefore, the expansion of the production scale of pharmaceutical preparations in the future will drive the further expansion of the pharmaceutical hollow capsule industry.